Improving Validation Practices in “Omics” Research
暂无分享,去创建一个
[1] P. Pye-Smith. The Descent of Man, and Selection in Relation to Sex , 1871, Nature.
[3] David R. Jones,et al. A systematic review and evaluation of the use of tumour markers in paediatric oncology: Ewing's sarcoma and neuroblastoma. , 2003, Health technology assessment.
[4] J. Ioannidis. Why Most Published Research Findings Are False , 2005, PLoS medicine.
[5] P. Donnelly,et al. Replicating genotype–phenotype associations , 2007, Nature.
[6] L. V. van't Veer,et al. Clinical application of the 70-gene profile: the MINDACT trial. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] S. Paik,et al. Development of the 21-gene assay and its application in clinical practice and clinical trials. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] M. Mann. Comparative analysis to guide quality improvements in proteomics , 2009, Nature Methods.
[9] K. Coombes,et al. Deriving chemosensitivity from cell lines: Forensic bioinformatics and reproducible research in high-throughput biology , 2009, 1010.1092.
[10] Robert E. Kearney,et al. A HUPO test sample study reveals common problems in mass spectrometry-based proteomics , 2009, Nature Methods.
[11] C. Ball,et al. Repeatability of published microarray gene expression analyses , 2009, Nature Genetics.
[12] S. Teutsch,et al. The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) initiative: methods of the EGAPP Working Group , 2009, Genetics in Medicine.
[13] Anne-Laure Boulesteix,et al. Over-optimism in bioinformatics: an illustration , 2010, Bioinform..
[14] D. Ransohoff. Proteomics research to discover markers: what can we learn from Netflix? , 2010, Clinical chemistry.
[15] M. Girolami,et al. Recommendations for Biomarker Identification and Qualification in Clinical Proteomics , 2010, Science Translational Medicine.
[16] K. Baggerly. Disclose all data in publications. , 2010, Nature.
[17] S. Sivapalaratnam,et al. More outreach for young scientists. , 2010 .
[18] John P. A. Ioannidis,et al. An empirical assessment of validation practices for molecular classifiers , 2011, Briefings Bioinform..
[19] J. Ioannidis,et al. Public Availability of Published Research Data in High-Impact Journals , 2011, PloS one.
[20] Andrew D. Johnson,et al. Temporal Trends in Results Availability from Genome-Wide Association Studies , 2011, PLoS genetics.
[21] D. Ransohoff,et al. Biomarker studies: a call for a comprehensive biomarker study registry , 2011, Nature Reviews Clinical Oncology.
[22] J. Ioannidis,et al. Comparison of effect sizes associated with biomarkers reported in highly cited individual articles and in subsequent meta-analyses. , 2011, JAMA.